ATM and B-cell chronic lymphocytic leukemia: Therefore, it appears that the ROS phenotype of ATM−/−DLBCL cell is different than that observed in ATM−/− CLL and may be linked to the antioxidant mechanism critical for malignant transformation in DLBCL.